Cargando…
Mechanistic Studies of Antibody-Mediated Clearance of Tau Aggregates Using an ex vivo Brain Slice Model
Recent studies have shown that immunotherapy clears amyloid beta (Aβ) plaques and reduces Aβ levels in mouse models of Alzheimer’s disease (AD), as well as in AD patients. Tangle pathology is also relevant for the neurodegeneration in AD, and our studies have shown that active immunization with an A...
Autores principales: | Krishnamurthy, Pavan K., Deng, Yan, Sigurdsson, Einar M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198029/ https://www.ncbi.nlm.nih.gov/pubmed/22025915 http://dx.doi.org/10.3389/fpsyt.2011.00059 |
Ejemplares similares
-
Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy
por: Congdon, Erin E., et al.
Publicado: (2016) -
Development of brain-penetrable antibody radioligands for in
vivo PET imaging of amyloid-β and tau
por: Banka, Vinay, et al.
Publicado: (2023) -
Alzheimer's Disease: Challenges Ahead
por: Sigurdsson, Einar M.
Publicado: (2010) -
The Fate of Tau Aggregates Between Clearance and Transmission
por: Seitkazina, Assel, et al.
Publicado: (2022) -
Spreading of P301S Aggregated Tau Investigated in Organotypic Mouse Brain Slice Cultures
por: Korde, Dhwani S., et al.
Publicado: (2022)